Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells. - Wikidata - awgldk - TriplyDB

Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.

Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.

http://www.wikidata.org/entity/Q34057949

about

Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion Apoptosis induced by knockdown of uPAR and MMP-9 is mediated by inactivation of EGFR/STAT3 signaling in medulloblastoma Prostate cancer relevant antigens and enzymes for targeted drug delivery Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer uPAR and cathepsin B-mediated compartmentalization of JNK regulates the migration of glioma-initiating cells Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas.Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis.Activity of plasma membrane V-ATPases is critical for the invasion of MDA-MB231 breast cancer cells.Cancer cell invasion: treatment and monitoring opportunities in nanomedicine.Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor Protease nexin 1 induces apoptosis of prostate tumor cells through inhibition of X-chromosome-linked inhibitor of apoptosis protein.Hyaluronan regulation of endothelial barrier function in cancer.Inhibitory effect of blue light emitting diode on migration and invasion of cancer cells.Interacting partners of macrophage-secreted cathepsin B contribute to HIV-induced neuronal apoptosis.Knockdown of cathepsin B and uPAR inhibits CD151 and α3β1 integrin-mediated cell adhesion and invasion in glioma Nucleophosmin Mutants Promote Adhesion, Migration and Invasion of Human Leukemia THP-1 Cells through MMPs Up-regulation via Ras/ERK MAPK Signaling MMP-9 and uPAR regulated glioma cell migration Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer.Strategies for tumor-directed delivery of siRNA.Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.Cathepsin B as a cancer target Clinical models and biochemical predictors of VTE in lung cancer.Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression.uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K/Akt signaling pathway in patients with rheumatoid arthritis.The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer.The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion.RNA interference-mediated knockdown of RhoGDI2 induces the migration and invasion of human lung cancer A549 cells via activating the PI3K/Akt pathway.INPP4B suppresses prostate cancer cell invasion Knock down of caveolin-1 affects morphological and functional hallmarks of human endothelial cells.Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-κB.Protease nexin 1: a novel regulator of prostate cancer cell growth and neo-angiogenesis.Lymphatic endothelial cells actively regulate prostate cancer cell invasion.Urokinase plasminogen activator receptor induced non-small cell lung cancer invasion and metastasis requires NHE1 transporter expression and transport activity.Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis

P2860

Q22000757-7D5F2965-BE1F-452A-896F-04F3805D7AD9 Q24298860-F3775486-015A-41E9-B475-A3F007CBEA3A Q27013843-23F1D53B-8777-4D36-B7FB-B8527CF5CE6B Q27306938-6385D432-8B53-46CD-958F-0697A224539B Q28237374-F04A1271-F9BF-451C-BCCA-AFD7D54A76C7 Q33742019-E79C7021-06BC-4DF5-A604-6B2B5BF0618B Q34993614-6572D7B6-8EBC-4AF9-98C0-E4CD524348C6 Q35055604-A90CC49A-C03D-4B68-8366-23C7C012DA94 Q35093966-44AC4112-7A59-49F8-BD6F-A701CE738867 Q35533533-21E9D608-B20F-4F61-AC21-67ED9819E1B1 Q35551870-61A7ADF3-925E-401B-B178-9C15E41F9D39 Q35751329-79CE9BF8-29C8-46BE-B554-4EC7BCA519AC Q36252341-ACEFABF3-C52B-4B2A-82C7-30004F92C90D Q36259524-D38DF792-1E72-4CE2-8E00-58C20501C733 Q36476417-33CF7EC2-AB1D-43BC-A60E-94059AB51B75 Q36534039-4845B800-A3E3-4BE6-8BB2-0FA431334A07 Q36542070-202FA2E8-C30B-445A-B7F0-6BEB3AD9668B Q37282934-A4F91BB4-D0FC-4EFA-B9FC-581D5D6D94A3 Q37840092-3D133803-8FB2-4B19-92EB-F21DFAE4AC81 Q38028961-EDDA7FAB-6226-471E-A8A2-51CB83CED0C2 Q38072054-0B368DAF-6F68-40F8-8938-0C4FCF2F4A89 Q38205701-AE84990A-45CC-49F6-BADD-35F871373D1E Q38224605-38DFA922-F63E-4EBB-8B81-20552A4E050B Q38721188-0EAAAEE8-A366-4562-BB07-D43A559B0AB5 Q38809660-6244F309-B043-4B9F-8EE0-9B24122DDED2 Q38858833-F181087A-DCD1-4A1E-B661-0BC8E0F77BC5 Q38952177-A30D5F61-EEB9-4352-92EC-BE1F9A693622 Q38953956-2DA05B23-105B-4B2E-8B91-4E969758B14C Q39184910-28DD729C-6FE3-4A5B-AF0E-4D80B6D312CD Q43069624-07DACA05-F346-443E-BB73-0EDAB4461B82 Q43105353-0E7294A4-6D57-4895-B33E-59DB9865813C Q52871186-79FE29E3-7D9B-4705-920F-79924051D0BB Q53275050-06529316-1CC0-490F-A58B-8CB8BF64D2DE Q58763841-AC9FA8D0-2735-4A8E-8F77-D0B6F1C818C8

P2860

Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.

http://www.wikidata.org/entity/Q34057949

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Targeting MMP-9, uPAR, and cat ...... osis in prostate cancer cells.

@ast

Targeting MMP-9, uPAR, and cat ...... osis in prostate cancer cells.

@en

Targeting MMP-9, uPAR, and cat ...... osis in prostate cancer cells.

@nl

type

label

Targeting MMP-9, uPAR, and cat ...... osis in prostate cancer cells.

@ast

Targeting MMP-9, uPAR, and cat ...... osis in prostate cancer cells.

@en

Targeting MMP-9, uPAR, and cat ...... osis in prostate cancer cells.

@nl

prefLabel

Targeting MMP-9, uPAR, and cat ...... osis in prostate cancer cells.

@ast

Targeting MMP-9, uPAR, and cat ...... osis in prostate cancer cells.

@en

Targeting MMP-9, uPAR, and cat ...... osis in prostate cancer cells.

@nl

P1433

Q34057949-511CB78B-FEFE-47A7-A910-9DC9706C1FA2

P1476

Q34057949-AAB360DB-3614-4067-9B71-8ADFD397CF92

P2093

Q34057949-2948A6BF-F73C-4C70-9C31-3A607E28B275

Q34057949-3A59BAFF-E44E-493D-8970-27FB8600C8F2

Q34057949-4CECAC16-7C6F-4463-B473-C5F09E0F37BA

Q34057949-9B51F78E-E75D-4C46-930B-BA7D344BD352

Q34057949-CACFCCFC-55BD-4BA8-A3B7-2CFE77E7C74F

P2860

Q34057949-04C59E2B-7F8F-4DF9-B89C-0A3FF6216D22

Q34057949-0A503509-D862-41CE-BA78-685FFFE26332

Q34057949-15DA2137-6A45-44FD-AB8D-DEE763EF72E7

Q34057949-16A66DBF-85A0-411E-B2B7-DAB77E555593

Q34057949-1BD4E7F6-3D0D-40AC-AA60-92376FC4B5A0

Q34057949-1CD012D1-63EC-4A41-B032-2E29821FF8AA

Q34057949-1DD4B783-B5F0-4BEA-9BC6-08DD507DBFF8

Q34057949-22BB6892-C4C5-4928-AD46-28D752AD08D5

Q34057949-23E46286-FBDE-4DE6-9FD7-83D2B0984E41

Q34057949-2460B384-6BA8-449F-A0CF-5BBE7995F07E

P2888

Q34057949-7411FF3E-4CE1-4BCB-8CDE-30A08F68D73F

P304

Q34057949-F423FAC8-EAE6-4469-83CD-68067EEF28E5

P31

Q34057949-C6E08684-B5A3-4633-BC02-17DE8217F371

P356

Q34057949-D041630B-BD3D-4E35-AB07-5283EED15DBD

P433

Q34057949-A1AEB4D2-8D23-45AB-80D2-8ECDB5561025

P478

Q34057949-A31086C9-C830-48BC-A071-D520F960FFDC

P577

Q34057949-93820151-8789-42C3-AA5C-D6C03EAA016F

P5875

Q34057949-59F384EE-0A53-4503-9D34-7030BFF87248

P698

Q34057949-05FC6AB9-C273-4546-8348-EB3B9ED3F89A

P932

Q34057949-43903362-3F26-4584-B1DB-3C8F41F6291A

P356

P1433

Cancer Gene Therapy

P1476

Targeting MMP-9, uPAR, and cat ...... osis in prostate cancer cells.

@en

P2093

A K Nalla

http://www.w3.org/2001/XMLSchema#string

B Gorantla

http://www.w3.org/2001/XMLSchema#string

C S Gondi

http://www.w3.org/2001/XMLSchema#string

J S Rao

http://www.w3.org/2001/XMLSchema#string

S S Lakka

http://www.w3.org/2001/XMLSchema#string

P2860

A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

Caspases: pharmacological manipulation of cell death

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo

Cancer statistics, 2008

Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

Caspases: enemies within

New functions for the matrix metalloproteinases in cancer progression

Lysosomal cathepsin B participates in the podosome-mediated extracellular matrix degradation and invasion via secreted lysosomes in v-Src fibroblasts.

P2888

P304

599-613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CGT.2010.16

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44579035

http://www.w3.org/2001/XMLSchema#string

P698

20448670

http://www.w3.org/2001/XMLSchema#string

P932

2919627

http://www.w3.org/2001/XMLSchema#string